Choline C 11 (The University of Texas MD Anderson Cancer Center)
Welcome to the PulseAid listing for the Choline C 11 drug offered from The University of Texas MD Anderson Cancer Center. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | The University of Texas MD Anderson Cancer Center |
| NON-PROPRIETARY NAME: | Choline C 11 |
| SUBSTANCE NAME: | CHOLINE C-11 |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-10-29 |
| END MARKETING DATE: | 0000-00-00 |
Choline C 11 HUMAN PRESCRIPTION DRUG Details:
| Item Description | Choline C 11 from The University of Texas MD Anderson Cancer Center |
| LABELER NAME: | The University of Texas MD Anderson Cancer Center |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 33.1(mCi/mL) |
| START MARKETING DATE: | 2015-10-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60215-110_d7ba3378-4b8d-42ab-8e38-abab72a7418e |
| PRODUCT NDC: | 60215-110 |
| APPLICATION NUMBER: | ANDA205690 |
Other CHOLINE C-11 Pharmaceutical Manufacturers / Labelers:
